Literature DB >> 9052404

Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma.

A M Björkqvist1, L Tammilehto, S Anttila, K Mattson, S Knuutila.   

Abstract

Comparative genomic hybridization (CGH) analyses were performed on 27 human pleural mesothelioma tumour specimens, consisting of 18 frozen tumours and nine paraffin-embedded tumours, to screen for gains and losses of DNA sequences. Copy number changes were detected in 15 of the 27 specimens with a range from one to eight per specimen. On average, more losses than gains of genetic material were observed. The loss of DNA sequences occurred most commonly in the short arm of chromosome 9 (p21-pter), in 60% of the abnormal specimens. Other losses among the abnormal specimens were frequently detected in the long arms of chromosomes 4 (q31.1-qter, 20%), 6 (q22-q24, 33%), 13 (33%),14 (q24-qter, 33%) and 22 (q13, 20%). A gain in DNA sequences was found in the long arm of chromosome 1 (cen-qter) in 33% of the abnormal specimens. Our analysis is the first genome-wide screening for gains and losses of DNA sequences using comparative genomic hybridization in malignant pleural mesothelioma tumours. The recurrent DNA sequence changes detected in this study suggest that the corresponding chromosomal areas most probably contain genes important for the initiation and progression of mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052404      PMCID: PMC2063309          DOI: 10.1038/bjc.1997.91

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Nonrandom chromosome alterations in human malignant mesothelioma.

Authors:  N C Popescu; A P Chahinian; J A DiPaolo
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

3.  Molecular deletion of 9p sequences in non-small cell lung cancer and malignant mesothelioma.

Authors:  R Center; R Lukeis; E Dietzsch; M Gillespie; O M Garson
Journal:  Genes Chromosomes Cancer       Date:  1993-05       Impact factor: 5.006

4.  Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.

Authors:  J Q Cheng; S C Jhanwar; Y Y Lu; J R Testa
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

5.  Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies.

Authors:  M Tiainen; A Hopman; O Moesker; F Ramaekers; M Wessman; A Laasonen; S Pyrhönen; L Tammilehto; K Mattson; S Knuutila
Journal:  Cancer Genet Cytogenet       Date:  1992-09

6.  Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.

Authors:  K Pelin-Enlund; K Husgafvel-Pursiainen; L Tammilehto; M Klockars; K Jantunen; B I Gerwin; C C Harris; T Tuomi; E Vanhala; K Mattson
Journal:  Carcinogenesis       Date:  1990-04       Impact factor: 4.944

7.  Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma.

Authors:  S Pyrhönen; A Laasonen; L Tammilehto; J Rautonen; S Anttila; K Mattson; L R Holsti
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

8.  Codeletion of p15 and p16 in primary malignant mesothelioma.

Authors:  S Xio; D Li; J Vijg; D J Sugarbaker; J M Corson; J A Fletcher
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

9.  Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.

Authors:  W L Flejter; F P Li; K H Antman; J R Testa
Journal:  Genes Chromosomes Cancer       Date:  1989-11       Impact factor: 5.006

10.  Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.

Authors:  M Tiainen; L Tammilehto; J Rautonen; T Tuomi; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

View more
  27 in total

1.  Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p.

Authors:  Z Adám; R Adány; A Ladányi; J Tímár; M Balázs
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features. Comparative genomic hybridization evidence for a mesothelioma subgroup.

Authors:  M Krismann; K M Müller; M Jaworska; G Johnen
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

Review 3.  The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.

Authors:  Isabelle Opitz; Thomas A D'Amico; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

4.  Comparative genomic hybridisation in malignant deciduoid mesothelioma.

Authors:  A Scattone; A Pennella; M Gentile; M Musti; P Nazzaro; A L Buonadonna; A Marzullo; D Cavone; L Pollice; G Serio
Journal:  J Clin Pathol       Date:  2006-03-28       Impact factor: 3.411

5.  Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma.

Authors:  Brock C Christensen; E Andres Houseman; Graham M Poage; John J Godleski; Raphael Bueno; David J Sugarbaker; John K Wiencke; Heather H Nelson; Carmen J Marsit; Karl T Kelsey
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

6.  DNA copy number changes in development and progression in leiomyosarcomas of soft tissues.

Authors:  W El-Rifai; M Sarlomo-Rikala; S Knuutila; M Miettinen
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

7.  Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Authors:  Thierry Jahan; Lin Gu; Robert Kratzke; Arkadiusz Dudek; Gregory A Otterson; Xiaofei Wang; Mark Green; Everett E Vokes; Hedy Lee Kindler
Journal:  Lung Cancer       Date:  2011-12-22       Impact factor: 5.705

8.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

9.  LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma.

Authors:  Guo-Liang Huang; Bin-Kui Li; Mei-Yin Zhang; Hui-Zhong Zhang; Rong-Rong Wei; Yun-Fei Yuan; Ming Shi; Xiao-Qian Chen; Long Huang; An-Hua Li; Bi-Jun Huang; Hong-Hua Li; Hui-Yun Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

Review 10.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.